Quell, A Non-Medication Solution for Chronic Pain: Interview with CEO Shai Gozani
Chronic pain affects 100 million Americans and is the most common cause of long-term disability. Long-term use of pain medications has significant risks, and chronic pain is a major contributor to opioid overuse.
NeuroMetrix hopes to offer effective, non-medication solutions for chronic pain. The Waltham, MA-based company has developed the Quell wearable device, which uses principles of neurostimulation to decrease the sensation of chronic pain. In a newly published study, 4 out of 5 users reported decreased pain after 60 days of use.
We spoke with NeuroMetrix founder and CEO Shai Gozani, MD, PhD, to find out more about the product and the company.
We're here for you.or call 800.204.6577